Penumbra has launched its new POD (Penumbra occlusion device) packing coil in the USA. The POD packing coil is designed for use with the company’s Ruby and POD embolisation products.
Penumbra has developed a suite of thrombectomy and embolisation products for use in a range of peripheral vascular conditions, and these products are driving significant growth:
- Penumbra’s embolisation platform includes Ruby, POD and the new POD Packing Coil, which is designed to pack very densely behind Ruby and POD to occlude arteries and veins throughout the peripheral vasculature, including aneurysms.
- Penumbra’s next-generation Indigo System is a continuous aspiration thrombectomy device designed to remove fresh, soft emboli and thrombi from the peripheral arteries and veins. The Indigo System includes four catheter sizes (CAT 3, 5, 6 and 8). The aspiration lumen is paired with a proprietary continuous vacuum aspiration pump to evacuate clot effectively and efficiently.
“With the Indigo System and POD, Penumbra has recently introduced products that have had significant impact on the treatment of vascular disease. Indigo represents a significant advancement in the treatment of thrombotic and embolic disease, which until now has had limited treatment options,” says Corey Teigen, at Sanford Health in Fargo, who uses Penumbra’s peripheral vascular products. “With the Indigo System, physicians now have the ability to remove limb- and life-threatening clots quickly and efficiently. Likewise the POD, Ruby and now the POD Packing Coil optimise embolisation procedures by decreasing procedure time while providing increased control.”
Adam Elsesser, chairman and CEO of Penumbra, says, “We are intent on changing treatment paradigms to improve clinical outcomes across two large and growing markets: neuro and peripheral vascular.”
